Saturday, October 31, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1 Diabetes Drugs Linked to Greater Thyroid Hormone Sensitivity in Large Study

A cross-sectional study of 7,697 adults with type 2 diabetes found GLP-1 receptor agonist use was associated with lower TFQI values, a marker consistent with greater central…

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 29 16:11 ETSource: Bioengineer.org

From the source

GLP-1 Diabetes Drugs Linked to Greater Thyroid Hormone Sensitivity in Large Study

A cross-sectional study of 7,697 adults with type 2 diabetes found GLP-1 receptor agonist use was associated with lower TFQI values, a marker consistent with greater central thyroid hormone sensitivity.

Read at bioengineer.org
PeptiPrescribed peptides from $99/moSee all →